NASDAQ:NMTC NeuroOne Medical Technologies (NMTC) Stock Price, News & Analysis $1.12 +0.04 (+3.70%) Closing price 10/9/2026 04:00 PM EasternExtended Trading$1.12 +0.00 (+0.18%) As of 10/9/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC Filings About NeuroOne Medical Technologies Stock (NASDAQ:NMTC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get NMTC alerts:Sign Up Key Stats Today's Range$1.04▼$1.1450-Day Range$0.99▼$2.1852-Week Range$0.96▼$6.42Volume80,148 shsAverage Volume186,676 shsMarket Capitalization$10.20 millionP/E RatioN/ADividend YieldN/APrice Target$7.33Consensus RatingHold Company Overview NeuroOne Medical Technologies Corporation is a medical device company focused on developing and commercializing technologies for recording, monitoring, and treating neurological disorders. Its products are designed for use by neurosurgeons and neurologists in procedures involving the brain and nervous system, including the diagnosis and treatment of epilepsy and other neurological conditions. The company’s product portfolio includes the Evo cortical and stereoelectroencephalography (sEEG) electrode systems, which are used to record electrical activity in the brain. NeuroOne is also developing the OneRF Ablation System, a technology intended to deliver radiofrequency energy to targeted areas of the brain for therapeutic procedures. The company has emphasized electrode designs intended to support minimally invasive procedures and provide recording and therapeutic capabilities. NeuroOne was founded in 2009 and is headquartered in Eden Prairie, Minnesota. Its products are primarily developed for the U.S. neurosurgical market, with potential applications in international markets as regulatory approvals and commercial opportunities develop. The company is led by Chief Executive Officer and President Dave Rosa, who has been involved in the development and commercialization of medical device technologies.AI Generated. May Contain Errors. Read More NeuroOne Medical Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks68th Percentile Overall ScoreNMTC MarketRank™: NeuroOne Medical Technologies scored higher than 68% of companies evaluated by MarketBeat, and ranked 114th out of 881 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingHold Consensus RatingNeuroOne Medical Technologies has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on no strong buy ratings, 3 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialNeuroOne Medical Technologies has a consensus price target of $7.33, representing about 554.8% upside from its current price of $1.12.Amount of Analyst CoverageNeuroOne Medical Technologies has only been the subject of 2 research reports in the past 90 days.Read more about NeuroOne Medical Technologies' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for NeuroOne Medical Technologies are expected to decrease in the coming year, from ($0.39) to ($0.71) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of NeuroOne Medical Technologies is -1.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of NeuroOne Medical Technologies is -1.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNeuroOne Medical Technologies has a P/B Ratio of 1.32. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about NeuroOne Medical Technologies' valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.23% of the float of NeuroOne Medical Technologies has been sold short.Short Interest Ratio / Days to CoverNeuroOne Medical Technologies has a short interest ratio ("days to cover") of 1.19, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in NeuroOne Medical Technologies has recently increased by 135.85%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldNeuroOne Medical Technologies does not currently pay a dividend.Dividend GrowthNeuroOne Medical Technologies does not have a long track record of dividend growth. News and Social Media3.6 / 5News Sentiment0.70 News SentimentNeuroOne Medical Technologies has a news sentiment score of 0.70. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.39 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 11 news articles for NeuroOne Medical Technologies this week, compared to 2 articles on an average week.Search InterestOnly 3 people have searched for NMTC on MarketBeat in the last 30 days. This is a decrease of -40% compared to the previous 30 days.MarketBeat Follows3 people have added NeuroOne Medical Technologies to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Company Ownership3.5 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $66,999.00 in company stock, which represents 0.6566% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, NeuroOne Medical Technologies insiders have bought more of their company's stock than they have sold. Specifically, they have bought $66,999.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders11.80% of the stock of NeuroOne Medical Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions16.07% of the stock of NeuroOne Medical Technologies is held by institutions.Read more about NeuroOne Medical Technologies' insider trading history. Receive NMTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NeuroOne Medical Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NMTC Stock News HeadlinesNeuroOne® Joins Dartmouth-Led Research Team on $1 Million NIH Grant to Advance Neurotransmitter Sensing TechnologyOctober 8 at 7:26 PM | markets.businessinsider.comNeuroOne (NASDAQ: NMTC) secures a $4.5M order as revenue climbs againOctober 7 at 2:03 AM | americanbankingnews.comTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered. Buried inside is what some call the legal groundwork for the biggest change to American money in over a century, with a key Treasury vote potentially as soon as January 18. Ian King, Chief Strategist at Strategic Fortunes, breaks down what the order could mean for the dollar and the financial system. | Banyan Hill Publishing (Ad)NeuroOne Gains After Q4 Product Revenue Rises 38%October 5, 2026 | rttnews.comNeuroOne Reports Preliminary Fiscal Q4 and Full-Year 2026 Product Revenue Growth, Tops Guidance with Record $4.5 Million OrderOctober 5, 2026 | quiverquant.comQNeuroOne NMTC Expects $3.8 Million Fiscal Q4 Product RevenueOctober 5, 2026 | quiverquant.comQNeuroOne Reports Preliminary Fiscal Q4 Product Revenue Growth of 38.4%; Secures Record $4.5 Million Purchase OrderOctober 5, 2026 | globenewswire.comHead to Head Analysis: Innovative Eyewear (NASDAQ:LUCY) and NeuroOne Medical Technologies (NASDAQ:NMTC)October 4, 2026 | americanbankingnews.comSee More Headlines NMTC Stock Analysis - Frequently Asked Questions How have NMTC shares performed this year? NeuroOne Medical Technologies' stock was trading at $4.5480 at the beginning of the year. Since then, NMTC stock has decreased by 75.4% and is now trading at $1.12. How were NeuroOne Medical Technologies' earnings last quarter? NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) posted its earnings results on Thursday, August, 13th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by $0.07. The firm earned $1.97 million during the quarter, compared to analysts' expectations of $2.17 million. NeuroOne Medical Technologies had a negative trailing twelve-month return on equity of 128.12% and a negative net margin of 71.50%. Read the conference call transcript. When did NeuroOne Medical Technologies' stock split? NeuroOne Medical Technologies shares reverse split before market open on Wednesday, April 15th 2026.A 1-6 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, April 14th 2026. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split. When did NeuroOne Medical Technologies IPO? NeuroOne Medical Technologies (NMTC) raised $500,000 in an initial public offering (IPO) on Wednesday, May 26th 2021. The company issued 10,000,000 shares at a price of $0.05 per share. How do I buy shares of NeuroOne Medical Technologies? Shares of NMTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of NeuroOne Medical Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that NeuroOne Medical Technologies investors own include Schwab US Large-Cap ETF (SCHX), NVIDIA (NVDA), Advanced Micro Devices (AMD), NIO (NIO), Ford Motor (F), Meta Platforms (META) and Plug Power (PLUG). Company Calendar Last Earnings8/13/2026Today10/10/2026Next Earnings (Estimated)12/15/2026Fiscal Year End9/30/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (2m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 NMTC's financial health is in the Red zone, according to TradeSmith. NMTC has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:NMTC CIK1500198 Webwww.n1mtc.com Phone(952) 426-1383FaxN/AEmployees18Year FoundedN/APrice Target and Rating Average Price Target for NeuroOne Medical Technologies$7.33 High Price Target$9.00 Low Price Target$5.00 Potential Upside/Downside+554.8%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($0.95) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$3.61 million Net Margins-71.50% Pretax Margin-74.46% Return on Equity-128.12% Return on Assets-86.34% Debt Debt-to-Equity RatioN/A Current Ratio2.84 Quick Ratio1.71 Sales & Book Value Annual Sales$12.10 million Price / Sales0.84 Cash FlowN/A Price / Cash FlowN/A Book Value$0.85 per share Price / Book1.32Miscellaneous Outstanding Shares9,110,000Free Float8,031,000Market Cap$10.20 million OptionableOptionable Beta0.77 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (NASDAQ:NMTC) was last updated on 10/10/2026 by MarketBeat.com Staff. From Our PartnersFederal Reserve Reveals Disturbing New Plan To Control Your MoneyA Federal Reserve filing, Docket No. OP-1670, is drawing scrutiny for language that could expand the Fed's vis...Weiss Ratings | SponsoredA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredMy next big call (under $1)On the first day of October, one of the biggest banks in the world changed its mind about Bitcoin. Citigroup r...Crypto 101 Media | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...Traders Agency | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredA simple options setup that cuts through the noiseIan Cooper says most options traders overcomplicate the process, juggling countless indicators, strategies, an...TradeWins | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroOne Medical Technologies Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroOne Medical Technologies With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
